Lind Kevin Robert Insider Trades

Insider Trading History

Track insider trading activity for Lind Kevin Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $358k 20,100 shares
Last Trade
Jun 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$281k 20,100 shares
$13.96
$17.83
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $24.4k 1,370 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 1,370 shares
$14.93
$17.83
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $15.1k 848 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.4k 848 shares
$18.16
$17.83
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $717k 40,200 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 40,200 shares
$12.96
$17.83
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
President And CEO
Holding Value $0 0 shares
Last Trade
Dec 02, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66.3M 1,106,144 shares
$59.98
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
President And CEO
Holding Value $0 0 shares
Last Trade
Dec 02, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$21.8M 363,740 shares
$60.00
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $21.8M 363,740 shares
Last Trade
Nov 13, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$4.78M 80,000 shares
$59.78
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $15.3M 255,377 shares
Last Trade
Nov 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$766k 12,808 shares
$59.78
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $26.6M 443,740 shares
Last Trade
Nov 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$766k 12,808 shares
$59.78
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $1.32M 22,000 shares
Last Trade
Oct 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 22,000 shares
$59.60
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $25.8M 430,932 shares
Last Trade
Aug 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.88M 82,482 shares
$34.88
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $16.1M 268,185 shares
Last Trade
Aug 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.88M 82,482 shares
$34.88
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $19.9M 332,134 shares
Last Trade
Feb 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.42M 332,134 shares
$19.32
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $19.5M 325,850 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.42M 325,850 shares
$4.35
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
CEO
Holding Value $11.7M 195,000 shares
Last Trade
Feb 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$819k 195,000 shares
$4.20
$59.98
Longboard Pharmaceuticals
Longboard Pharmaceuticals LBPH
President And CEO
Holding Value $20.9M 348,450 shares
Last Trade
Mar 11, 2021 Sale
No data
No data
$59.98
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CFO
Holding Value $7M 70,000 shares
Last Trade
Mar 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.12M 70,000 shares
$44.60
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CFO
Holding Value $796k 7,957 shares
Last Trade
Feb 13, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$242k 4,500 shares
$53.82
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CFO
Holding Value $346k 3,457 shares
Last Trade
Feb 13, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$248k 4,500 shares
$55.00
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
Executive VP And CFO
Holding Value $12.8M 128,000 shares
Last Trade
Feb 13, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$242k 4,500 shares
$53.82
$99.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up